Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
rosacea eczema alopecia ceramide keratosis pityriasis basal cell melanoma keratosis purpuraYour Article Summary
Neutrophilic dermatosis complicating lenalidomide therapy
Journal of the American Academy of Dermatology, 08/26/09
Thieu KP et al. – The treatment of myelodysplastic syndrome and is currently under investigative use for metastatic melanoma. The authors present a case of neutrophilic dermatosis involving predominantly the lower extremities in a patient receiving lenalidomide therapy for multiple myeloma.
Related Articles
Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial : The Lancet Oncology
The Lancet Oncology - Online First, 10/23/09
Relevance Score: 93%
Results of a multicenter, randomized, double-blind phase 2/3 study of lenalidomide in the treatment of pretreated relapsed or refractory metastatic malignant melanoma
Cancer, 10/30/09
Relevance Score: 91%
Multicenter, Phase I, Dose-Escalation Trial of Lenalidomide Plus Bortezomib for Relapsed and Relapsed/Refractory Multiple Myeloma
Journal of Clinical Oncology, 11/20/09
Relevance Score: 90%
Multicenter, Phase I, Dose-Escalation Trial of Lenalidomide Plus Bortezomib for Relapsed and Relapsed/Refractory Multiple Myeloma
Journal of Clinical Oncology, 10/02/09
Relevance Score: 89%
Survival effect of venous thromboembolism in patients with multiple myeloma treated with lenalidomide and high-dose dexamethasone
Journal of Clinical Oncology, 11/13/09
Relevance Score: 88%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Intensified Inflammatory Reaction of Actinic Keratoses after Single Application of Topical 5-Fluorouracil in a Patient Treated with Nilotinib for Chronic Myeloid Leukemia
Dermatology, 12/07/09
Severe atopic dermatitis treated with everolimus
Journal of Dermatological Treatment , 12/07/09
Silver enhances the in vitro antifungal activity of the saponin, CAY-1
Mycoses, 12/07/09
Sponsor
Article Search
Sponsor


See Latest Articles


